Laro Duo Tablet

Adult dose

Once daily, 1 tablet orally.

This medication may increase the risk of blood clots in the bloodstream, so caution is required for patients at high risk of thrombosis. Especially if immobilization occurs, treatment with this medication should be discontinued and may be resumed once symptoms improve. As this medication is primarily metabolized in the liver, patients with impaired liver function should avoid its use or be carefully monitored. It is not recommended for use in premenopausal women, and women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It is not used for the prevention of cardiovascular diseases, and caution is needed for patients with a history of stroke or at high risk of stroke. If any abnormal symptoms such as breast or uterine bleeding occur while taking this medication, consult a doctor immediately. Common symptoms that may appear include facial flushing due to vasodilation, leg cramps, cold symptoms, and peripheral edema, so symptoms should be carefully monitored. Moreover, this medication should not be administered to patients with certain genetic issues or hypercalcemia and those with kidney stones. There may be interactions when used with other drugs, so inform healthcare providers of any medications being taken. In case of overdose, symptoms such as dizziness, vomiting, and muscle cramps may occur, so dosage must be strictly adhered to. Safety and efficacy have not been established for children, so it is not used in this population. This medication should be stored out of reach of children and it is advisable not to transfer it to other containers.

Serious side effects

Venous thromboembolism including deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, thrombophlebitis, thrombocytopenia, hypertension, headaches including migraines, rash, venous thromboembolism, arterial thromboembolism, retinal vein occlusion, stroke, death related to venous thromboembolism, symptoms due to hypercalcemia and hypercalciuria, severe allergic reactions, severe skin abnormal reactions, respiratory issues, liver abnormalities (jaundice), severe kidney

Mild side effects

• Vasodilation (facial flushing)
• leg cramps
• cold symptoms
• peripheral edema
• slight decrease in platelet count
• moderate increase in AST and/or ALT
• gallstones
• vaginal bleeding
• facial swelling
• heartburn

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius room temperature. This will help you safely maintain the medication's effectiveness.

Appearance

Yellow, biconvex, round film-coated tablet

Package unit

30 tablets/bottle